Phase III EMBRACA study meets primary endpoint of PFS with talazoparib over chemotherapy Dec. 29, 2017
CD229 CAR T cells demonstrate strong cytotoxic activity, selectivity in models of multiple myeloma Dec. 29, 2017
Descartes-08 cells demonstrate promising antitumor effect in preclinical models of multiple myeloma Dec. 29, 2017
Treatment with CRISPR-Cas9 improves motor function and extends survival in mouse model of ALS Dec. 29, 2017
FDA approves expanded indication for Procysbito to include children 1 year of age and older Dec. 29, 2017
RSS